2nd Conference of the Patient Centric Medicines Initiative (PaCeMe In)  | KN 6782

Tailor medicines for older patients in pharmaceutical development: From new regulations to a rational science based process 05.06. - 06.06.2019 | Berlin, Germany


Abba Berlin Hotel
Lietzenburger Str. 89
10719 Berlin
Tel.:0049 30 887 186 0

Kursprogramm zum Download


As an outcome of the 1st Conference on patient centric product development, the Patient Centric Medicine (PaCeMe) initiative was established early 2018 as a multidisciplinary industrial-academic collaboration to develop practical guidance to comply with future patient centric product development.

The 2nd conference on patient centric product development is titled:
Tailor medicines for older patients in pharmaceutical development: From new regulations to a rational science based process

The conference bring together key opinion leaders from different disciplines including patient representatives to provide their expertise and thoughts as well as to discuss the results of the PaCeMe Initiative stakeholders in workshops with the attendees.



  • of the pharmaceutical industry (formulation development, product development, clinical and commercial manufacturing, regulatory affairs, medical science and marketing)
  • and academy (pharma technology and students).

Hospital pharmacists, community pharmacists as well as regulatory authorities.


The objective is to provide a pragmatic road map and achieve a general consensus that we can do it and even better.

The multidisciplinary and distinguished speaker panel will touch on different aspects of patient centric drug product development, its importance for effectiveness and drug safety, and especially how this can become an integral mind set for drug product development.

Areas that will be discussed in details are:

  • Ethical aspects of patient centric products for older and multimorbid patients
  • Patient characteristics and needs from medical, epidemiological, sociological and pharmaceutical practice
  • Thoughts and considerations on ongoing and future regulation
  • Case studies of involving patients in drug development and product design
  • Successful industrial development of a patient centric drug product

Finally, all conference attendees will be involved by a moderated interactive discussion on a proposed “road map” for patient centric drug product development as a way forward to a scientific rational, meaningful and commercially viable “road map” for patient centric product design.


Sven Stegemann, Ph.D.

Prof. Dr. Sven Stegemann is director, pharmaceutical business development at Capsugel, and professor of patient centric drug design and manufacturing at the Graz University of Technology, Austria.

Over the course of his 18-year career at Capsugel, Dr. Stegemann has worked as an advisor to major pharmaceutical companies on ways to improve the design, development and manufacture of pharmaceutical products so they better address the individual needs of patients.

In his academic role, Dr. Stegemann’s focuses his research on the rational development of patient centric drug products and their associated manufacturing technologies, as well as education and
training of students and young scientists.

Dr. Stegemann is the founder and chair of the AAPS Focus Group on Patient-Centric Drug Development, Product Design, and Manufacturing as well as the founder and President of the Geriatric Medicine Society.


Industry 1.490,00 €
Authority / University 745,00 €
Students 178,00 €
Alle Preise mehrwertsteuerfrei gemäß § 4,22 UStG



Dr. Martin Bornhöft
Tel.: +49 6131 9769-0
Fax: +49 6131 9769-69
E-Mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/